← Back
$IKT All transactions

Inhibikase Therapeutics, Inc.

A

$ Value

$0

Shares

602,346

Price

$0

Filed

Jul 2

Insider

Name

Iwicki Mark T

Title

Chief Executive Officer

CIK

0001415537

Roles

Director Officer

Transaction Details

Transaction Date

2025-02-21

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

602,346

Footnotes

The Reporting Person's Form 4 filed with the SEC on February 25, 2025 inadvertently reported the incorrect exercise price and expiration date with respect to the stock option award originally granted on February 21, 2025 (the "Option Award"). This amendment is being filed solely to correct the exercise price and expiration date of the Option Award. | The options will vest and become exercisable in 48 substantially equal monthly installments beginning on March 21, 2025, subject to the Reporting Person's continued employment through such date.

Filing Info

Accession No.

0000950170-25-093441

Form Type

4/A

Issuer CIK

0001750149

Iwicki Mark T's History

Date Ticker Type Value
2025-12-12 MRUS U $7.1M
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0

Other Insiders at IKT (90d)

No other insider activity at this issuer in the last 90 days.